Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
7
58%
Ph phase_2
4
33%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
4(36.4%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(9)
Terminated(1)

Detailed Status

Completed9
Withdrawn1
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 24 (36.4%)
N/A7 (63.6%)

Trials by Status

withdrawn18%
completed975%
recruiting18%
enrolling_by_invitation18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12